Deciphera Pharmaceuticals

Patent cliffs & loss of exclusivity

Small Molecules

Company

Legal NameDeciphera Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/deciphera-pharmaceuticals
Fax Number785.830.2150
Full Address643 Massachusetts St, Suite 200 Lawrence, KS 66044
LinkedIn URLhttps://www.linkedin.com/company/deciphera-pharmaceuticals/
Pitchbook URLhttps://pitchbook.com/profiles/company/64797-94
Previous NameDeciphera Pharmaceuticals, LLC

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. QINLOCKRIPRETINIBSmall mol.Oct 2042
  2. ROMVIMZAVIMSELTINIBSmall mol.Apr 2045
  3. ROMVIMZAVIMSELTINIBSmall mol.Apr 2045
  4. ROMVIMZAVIMSELTINIBSmall mol.Apr 2045

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Deciphera Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio